tirzepatide and anxiety GLP-1s linked to lower rates of depression than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Study links semaglutide and tirzepatide

GLP-1 receptor: a new target for Sepsis

Clinical studies show that patients using GLP-1 medications for weight management, along with diet and exercise, typically lose 10-15% of their body weight within a year

Patients benefit from having a provider who can monitor progress, adjust recommendations, and provide continuity of care over time

Injectable administration bypasses your digestive system entirely, so the compounds reach effective levels faster than oral supplements

Your choice should reflect insurance coverage, genetic predispositions affecting peptide metabolism, and total cost of ownership over your treatment timeline